在肝硬化中便微生物移植的现在和未来
Asiya Tafader1, Jasmohan S Bajaj
1Department of Medicine, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia, USA.
概括
便微生物组移植 (FMT) 通过调节肠道微生物组和免疫系统来治疗肝硬化. 这种方法针对肠道失生症,这是肝硬化发展和并发症的关键因素.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肝硬化与渐进的肠道失调和免疫失调有关.
- 肠道微生物组的变化在肝硬化诊断之前发生.
- 肠肝轴在肝病进展中起着至关重要的作用.
研究的目的:
- 审查肠道微生物群在肝硬化中的作用.
- 突出便微生物组移植 (FMT) 作为肝硬化治疗策略.
- 讨论特定疾病的微生物变化及其对肝硬化并发症的影响.
主要方法:
- 文献综述侧重于肝硬化时肠道微生物组的改变.
- 对在肝硬化患者中检查便微生物组移植 (FMT) 的研究进行分析.
- 检查肠肝轴和肝硬化中的免疫反应.
主要成果:
- 肠道微生物组失调是肝硬化的一个标志,即使在早期阶段.
- 便微生物组移植 (FMT) 显示出在恢复肠道微生物平衡和改善肝功能方面的潜力.
- 微生物的变化对肝硬化相关的并发症有显著的贡献.
结论:
- 操纵肠道微生物群,特别是通过FMT,为肝硬化提供了一个有希望的治疗途径.
- 准肠肝轴和免疫失调对于治疗肝硬化至关重要.
- 对FMT和微生物组调制进行进一步的研究是必要的,以治疗肝硬化.
相关概念视频
01:50What is Monogastric Digestion?
70.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.6K
01:29Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1